Nominee Director Risks: A Practical Guide
A practical guide to nominee director risks: personal liability, loss of control, tax-residence traps, and how to use nominee directors safely and compliantly.
A practical guide to nominee director risks: personal liability, loss of control, tax-residence traps, and how to use nominee directors safely and compliantly.
Appointing a nominee director can look like a tidy solution. You need a resident director to satisfy a local rule, or you would prefer your own name to stay off a public file, and a provider offers to supply someone to sit on the board. The paperwork is simple and the cost is modest.
The risks, however, are not modest. A director is a director in the eyes of the law, whatever private understanding sits behind the appointment. Understanding nominee director risks before you appoint one is the difference between a useful arrangement and an expensive mistake.
This guide explains where the exposures lie, for both the beneficial owner and the nominee, and how a properly built arrangement contains them.
The core problem: a nominee holds real power
A nominee director is appointed to act on the beneficial owner's instructions. But the law does not recognise a category of director who has the title without the duties. Once appointed, the nominee holds the full legal authority of a director and owes the company the full range of directors' duties.
That asymmetry cuts both ways. The owner is trusting someone else with genuine power over the company. The nominee is accepting genuine responsibility for an entity they do not actually run.
Every well-known failure of nominee arrangements traces back to this single fact. The protections, indemnities, and instruments we discuss below all exist to manage a relationship in which legal power and economic interest have been deliberately separated.
Risks to the beneficial owner
Loss of control. The nominee can, in law, exercise the powers of a director. If the relationship breaks down, or the nominee becomes uncooperative, the owner may struggle to remove them or to redirect the company. We mitigate this with pre-signed undated resignations, powers of attorney, and clear contractual obligations, but no document fully removes the underlying dependency on the nominee's good faith.
Frozen operations. Banks frequently look to the named director to authorise account changes. A disengaged or unavailable nominee can stall transactions, signings, and renewals at the worst possible moment.
The shadow director trap. If the owner in fact directs the company while the nominee sits on the register, the owner can be treated as a shadow or de facto director. This imports director liabilities onto the owner while adding an appearance of concealment, which is the worst of both outcomes.
Reputational and audit risk. Counterparties, auditors, and acquirers increasingly probe board arrangements. A nominee that cannot explain or evidence its role can complicate financing, due diligence, and exits.
Risks to the nominee
The nominee is rarely the passive figure the label suggests.
Personal liability. In many jurisdictions a director can be personally liable for unpaid taxes, for trading while insolvent, for breaches of regulatory or environmental rules, and for failures of statutory filings. The nominee is exposed to these whether or not they made the underlying decisions.
Limited knowledge, full responsibility. A nominee often has little visibility into the company's day-to-day affairs yet bears responsibility for them. This is why serious professional nominees insist on indemnities, restrict the documents they will sign, and conduct their own due diligence on the owner and the business.
A nominee willing to sign anything without scrutiny is not offering a better service. They are signalling that they do not understand the risk, which makes them the weakest point in the structure.
The tax-residence trap
The most expensive nominee failure is rarely about control. It is about tax.
A company is commonly tax resident where it is centrally managed and controlled, or where effective management sits. If a nominee director in the country of incorporation simply approves decisions that are really made by the owner elsewhere, the company may be tax resident in the owner's country rather than where the board nominally meets.
The result can be unexpected corporate tax exposure, penalties, and the unravelling of the very benefit the structure was meant to deliver. A nominee who does not genuinely participate in governance does not create substance. They often destroy it, because the contrast between form and reality is laid bare.
Building a nominee arrangement that holds up
A defensible nominee arrangement shares several features.
It is documented, through a nominee agreement and, for shareholders, a declaration of trust that records the true position. It is disclosed to the parties entitled to know, including the registered agent, the bank, and any beneficial ownership register that requires the ultimate owner's identity. Privacy from a public register is legitimate; concealment from a regulator or bank is not.
Where substance is needed, the resident director genuinely participates, holding real meetings, exercising independent judgement, and keeping contemporaneous minutes. A regulated professional provider, accountable under its own compliance regime, is far safer than an informal arrangement with a friend or employee.
Finally, the arrangement matches reality. If the owner controls the company, the documentation should reflect that control rather than disguise it. Structures designed to create a false impression are precisely the ones that collapse under examination.
How HPT helps
We start by asking whether a nominee is the right answer at all. Often a cleaner ownership structure, a properly resourced local board, or a different jurisdiction removes the need entirely. Where a nominee genuinely fits, we appoint regulated providers, draft the protective instruments, and build the governance substance so the arrangement is compliant and resilient rather than fragile.
If you have been offered a nominee director, talk to us before you accept.
The director's note.
Once a quarter. Practical commentary from active mandates — banking, structures, mobility, regulation. No marketing send.
Related articles
Economic Substance Rules for Offshore Companies
Economic substance rules now apply across offshore jurisdictions. Here are the relevant activities, the substance test, penalties, and real substance.
Economic Substance Requirements by Jurisdiction
Economic substance requirements determine whether your offshore entity is respected. We explain the rules, how they vary by jurisdiction, and how to build.
Offshore Company Annual Compliance Checklist for 2026
An offshore company annual compliance checklist covering registry filings, economic substance, beneficial ownership, and accounting records for 2026.
Want this applied to your matter?
Five days from intake to a written diagnosis on how this topic affects your specific position.